RECENT POSTS
- Your First Move For Monday November 16th
- Web Extra: Where Will The Next Bull Come From?
- Burned by Yahoo!, Disney and More
- The Latest Picks That Paid – Friday November 13th
- Pops & Drops: Dow Chemical, Macy's...
- Chartology – Can Stocks Break Above 1100?
- Fast Action: Using Options To Play Housing Bottom
- Bold Call Of The Day – Microsoft
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
 |
The headline: Stocks Rise For Third Straight Day; Longest Winning Streak of 2008
It’s those old global themes of oil, retail and tech that added to the rally, Pete Najarian said.
But January’s rise in retail sales isn’t enough to make Jeff Macke a buyer of the retail space.
Guy Adami reiterated two of his favorite trades – Apache [APA
Loading...
()
] and Merck [MRK
Loading...
()
], the latter of which is just off its 52-week low.
MURDOCH TO FOIL MICROSOFT?
The headline: Yahoo (YHOO), News Corp. (NWS) Consider a Combination of Online Properties
News Corp. would reportedly take a 20% stake in Yahoo, which would likely help Yahoo fend off the hostile bid from Microsoft. But no one buys it. Karen Finerman, Pete Najarian and Jeff Macke – all Yahoo shareholders – voiced skepticism that the rumblings would ever materialize into a deal if for no other reason than that Yahoo shareholders would not let it happen. Pete said he continues to sell YHOO calls every month and take the gains.
BREAKING: Study Shows Genentech and Biogen Drug Rituxan Works on Multiple Sclerosis
CNBC’s Mike Huckman reported on a study just released in the New England Journal of Medicine that found that Rituxan, a joint-venture between Genentech
and Biodec
intended for use on rheumatoid arthritis and non-Hodgkin’s lymphoma, is also useful in treating M.S. According to the study, patients using Rituxan saw a 58% decrease in M.S. flare-ups and a 91% drop in brain legions after just two infusions of the drug.
This news has huge upside potential for Genetech, Huckman said. It could be a mixed bag for Biogen because the company makes two other multiple sclerosis drugs whose sales could be cannibalized by Rituxan.
But would that be the worse thing that could happen for Biogen? Pete Najarian thinks this solidifies his position that Biogen can be owned “from here to eternity.”
Jeff Macke said this could be a much-needed momentum push for Genentech.
TECH & TELECOM TRIUMPHANT:
The headline: Tech-Heavy Nasdaq Pops 2% as Intel (INTC), Cisco (CSC), Microsoft (MSFT) Surge
Guy Adami noted that semiconductor maker Applied Materials [AMAT
Loading...
()
] jumped 10% on its earnings as well. Tech was oversold, he said, and it’s time to look for the old tech stalwarts to come back.
Karen Finerman said that if she were building a tech portfolio, she would first look to Apple (AAPL) and Microsoft, which have the most value and are overshot to the downside.
FILL ‘ER UP:
The headline: Energy Stocks Fuel Rally After Report Shows Smaller-Than-Expected Oil Supplies
Oil Service stocks like Baker Hughes [BHI
Loading...
()
] and Schlumberger [SLB
Loading...
()
] also had big moves, Guy Adami pointed out. And the steel names were red-hot, too. Nucor [NUE
Loading...
()
] and U.S. Steel [X
Loading...
()
] are buys on their valuation and the chance that both could be takeover targets, according to Guy.
AG AWESOME AGAIN:
The headline: Ag Trade Making Fierce Comeback as Agrium (AGU) Reports Strong Earnings
Ag stocks can raise prices which not many other groups can do, Pete Najarian said. Their PE ratios may look high but it’s relative to their extreme growth rates.
Jeff Macke opined that it is just too hard to bet against these names anymore.
Guy Adami would buy Deere (DE) on any pullback.
CAN’T BEAT THE REAL THING:
The headline: Coca-Cola [KO
Loading...
()
] Profit Surges 79%, Boosted By Double-Digit Sales Growth In Emerging Markets
Coke is a play on emerging markets (it increased sales in India by 18% last quarter) as well as a weak U.S. dollar, according to Pete Najarian. But the fact that it didn’t increase its buyback is why the stock was lower Wednesday.
SUNNY DELIGHTS:
The headline: Solar-Power Stocks Surge After First Solar [FSLR
Loading...
()
] Reports Better-Than-Expected Earnings
Solar is the real deal, according to Pete Najarian. After soaring 30% on its earnings, First Solar looks a little rich to Pete but the upside bodes well for the sector, he said. And don’t forget that semiconductor stocks like Applied Materials (AMAT) and MEMC Electronics (WFR) are also plays on solar since they make the wafers that go into the panels.
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to .
Trader disclosure: On Feb.13, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (INTC), (YHOO), (DIS); Najarian Owns (BIIB), (C), (CSCO), (MCD), (MS), (MSFT), (YHOO), (XLF); Najarian Owns (AAPL) Calls; Najarian Owns (FRE) Puts; Finerman Owns (GS); Finerman's Firm Owns (AAPL), (GE), (MSFT), (WMT), (YHOO); Finerman's Firm And Finerman Own (HD); Finerman's Firm Is Short (SPY), (IJR), (IYR), (MDY), (IWM); Finerman's Firm Is Short (LEH) And Owns (LEH) Puts
Data is a real-time snapshot *Data is delayed at least 15 minutes